These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30370055)

  • 1.
    Nasiri MJ; Heidary M; Azimi T; Goudarzi H; Tabarsi P; Sarokhalil DD; Feizabadi MM
    New Microbes New Infect; 2018 Nov; 26():118-123. PubMed ID: 30370055
    [No Abstract]   [Full Text] [Related]  

  • 2. Clofazimine susceptibility testing of Mycobacterium avium complex and Mycobacterium abscessus: a meta-analysis study.
    Hajikhani B; Nasiri MJ; Hosseini SS; Khalili F; Karimi-Yazdi M; Hematian A; Nojookambari NY; Goudarzi M; Dadashi M; Mirsaeidi M
    J Glob Antimicrob Resist; 2021 Sep; 26():188-193. PubMed ID: 34153525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran.
    Daneshfar S; Khosravi AD; Hashemzadeh M
    PLoS One; 2022; 17(8):e0267320. PubMed ID: 35960778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rates of nontuberculous mycobacteria isolation from patients with presumptive tuberculosis in Iran.
    Nasiri MJ; Dabiri H; Fooladi AAI; Amini S; Hamzehloo G; Feizabadi MM
    New Microbes New Infect; 2018 Jan; 21():12-17. PubMed ID: 29188063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease.
    Winthrop KL; McNelley E; Kendall B; Marshall-Olson A; Morris C; Cassidy M; Saulson A; Hedberg K
    Am J Respir Crit Care Med; 2010 Oct; 182(7):977-82. PubMed ID: 20508209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients.
    Coolen-Allou N; Touron T; Belmonte O; Gazaille V; Andre M; Allyn J; Picot S; Payet A; Veziris N
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760130
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of diagnostic criteria for non-tuberculous mycobacterial disease to a case series of mycobacterial-positive isolates.
    Ghio AJ; Smith GS; DeFlorio-Barker S; Messier KP; Hudgens E; Murphy MS; Maillard JM; Stout JE; Hilborn ED
    J Clin Tuberc Other Mycobact Dis; 2019 Dec; 17():100133. PubMed ID: 31867444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality after Respiratory Isolation of Nontuberculous Mycobacteria. A Comparison of Patients Who Did and Did Not Meet Disease Criteria.
    Novosad SA; Henkle E; Schafer S; Hedberg K; Ku J; Siegel SAR; Choi D; Slatore CG; Winthrop KL
    Ann Am Thorac Soc; 2017 Jul; 14(7):1112-1119. PubMed ID: 28387532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults.
    Khan O; Chaudary N
    Drug Des Devel Ther; 2020; 14():2287-2294. PubMed ID: 32606598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of drug regimens and treatment outcome in patients with
    Dashtbin S; Mirkalantari S; Dadashi M; Darban-Sarokhalil D
    Expert Rev Anti Infect Ther; 2022 Jul; 20(7):1015-1023. PubMed ID: 35306950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the 2007 ATS/IDSA diagnostic criteria for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease.
    Chae DR; Kim YI; Kee SJ; Kim YH; Chi SY; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim SO; Kim YC; Lim SC
    Respiration; 2011; 82(2):124-9. PubMed ID: 20926850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Validity of Gastric Aspirate Culture in Nontuberculous Mycobacterial Pulmonary Disease.
    Hara R; Kitada S; Iwai A; Kuge T; Oshitani Y; Kagawa H; Tsujino K; Yoshimura K; Miki M; Miki K; Kida H
    Ann Am Thorac Soc; 2020 Dec; 17(12):1536-1541. PubMed ID: 32915655
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary Function in Metabolic Syndrome: A Meta-Analysis.
    Fang NN; Wang ZH; Li SH; Ge YY; Liu X; Sui DX
    Metab Syndr Relat Disord; 2022 Dec; 20(10):606-617. PubMed ID: 36125502
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary disease caused by Mycobacterium simiae in Iran's national referral center for tuberculosis.
    Baghaei P; Tabarsi P; Farnia P; Marjani M; Sheikholeslami FM; Chitsaz M; Gorji Bayani P; Shamaei M; Mansouri D; Masjedi MR; Velayati AA
    J Infect Dev Ctries; 2012 Jan; 6(1):23-8. PubMed ID: 22240424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on pulmonary lesions in which nontuberculous mycobacteria were detected by percutaneous aspiration--a proposal to add "culture positivity of percutaneous aspiration material" to the bacteriological diagnostic criteria of pulmonary nontuberculous mycobacterial diseases].
    Nakahara Y; Mochizuki Y; Kawamura T; Sasaki S; Morimoto A; Mizumori Y; Tsukamoto H; Watanabe E; Yokoyama T
    Kekkaku; 2013 Mar; 88(3):283-9. PubMed ID: 23672168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of class 1 integron in
    Karimi Dehkordi M; Halaji M; Nouri S
    Trop Med Health; 2020; 48():16. PubMed ID: 32280298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Non-Tuberculosis Mycobacterial Infections among Tuberculosis Suspects in Iran: Systematic Review and Meta-Analysis.
    Nasiri MJ; Dabiri H; Darban-Sarokhalil D; Hashemi Shahraki A
    PLoS One; 2015; 10(6):e0129073. PubMed ID: 26052701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Clinical Isolates of Mycobacterium simiae Using Drug Susceptibility Tests and Molecular Analyses.
    Dezhkhi H; Farnia P; Haddadi A; Farnia P; Velayati AA
    Curr Microbiol; 2021 Jun; 78(6):2324-2331. PubMed ID: 33847796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nontuberculous Mycobacteria Isolation from Clinical and Environmental Samples in Iran: Twenty Years of Surveillance.
    Velayati AA; Farnia P; Mozafari M; Mirsaeidi M
    Biomed Res Int; 2015; 2015():254285. PubMed ID: 26180788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.